NEW YORK STATE COMMON RETIREMENT FUND - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$2,629
+10.9%
65,727
+21.7%
0.00%0.0%
Q1 2024$2,371
-28.6%
53,989
+0.6%
0.00%
-40.0%
Q4 2023$3,321
+49.4%
53,688
+11.1%
0.01%
+66.7%
Q3 2023$2,223
-38.7%
48,327
-23.4%
0.00%
-40.0%
Q2 2023$3,627
+61.8%
63,116
+5.6%
0.01%
+66.7%
Q1 2023$2,242
+180.6%
59,786
+109.5%
0.00%
+200.0%
Q4 2022$799
-99.9%
28,533
+6.7%
0.00%0.0%
Q3 2022$752,000
-18.8%
26,746
+0.5%
0.00%0.0%
Q2 2022$926,000
-2.3%
26,604
+0.8%
0.00%0.0%
Q1 2022$948,000
+52.4%
26,400
-1.1%
0.00%0.0%
Q4 2021$622,000
+22.2%
26,704
-0.4%
0.00%0.0%
Q3 2021$509,000
-22.1%
26,798
-17.3%
0.00%0.0%
Q2 2021$653,000
+11.1%
32,404
+0.9%
0.00%0.0%
Q1 2021$588,000
-9.0%
32,1000.0%0.00%0.0%
Q4 2020$646,000
+7.3%
32,1000.0%0.00%0.0%
Q3 2020$602,000
-16.5%
32,1000.0%0.00%0.0%
Q2 2020$721,000
+51.5%
32,1000.0%0.00%0.0%
Q1 2020$476,000
-23.1%
32,1000.0%0.00%0.0%
Q4 2019$619,000
-17.7%
32,100
-15.3%
0.00%0.0%
Q3 2019$752,000
-30.4%
37,900
-26.0%
0.00%0.0%
Q2 2019$1,081,000
+3.3%
51,1890.0%0.00%0.0%
Q1 2019$1,046,000
+9.1%
51,189
+6.2%
0.00%0.0%
Q4 2018$959,000
+31.6%
48,186
+27.1%
0.00%0.0%
Q3 2018$729,000
+11.8%
37,900
-11.3%
0.00%0.0%
Q2 2018$652,000
-18.6%
42,7200.0%0.00%0.0%
Q1 2018$801,000
-2.6%
42,7200.0%0.00%0.0%
Q4 2017$822,000
+7.7%
42,7200.0%0.00%0.0%
Q3 2017$763,0000.0%42,7200.0%0.00%0.0%
Q2 2017$763,000
+23.3%
42,720
-0.0%
0.00%0.0%
Q1 2017$619,000
-20.6%
42,721
+0.9%
0.00%0.0%
Q4 2016$780,000
-2.9%
42,3200.0%0.00%0.0%
Q3 2016$803,000
+52.7%
42,320
+29.8%
0.00%0.0%
Q2 2016$526,000
+34.5%
32,6000.0%0.00%0.0%
Q1 2016$391,000
-15.7%
32,6000.0%0.00%0.0%
Q4 2015$464,000
+21.8%
32,6000.0%0.00%0.0%
Q3 2015$381,000
-11.2%
32,600
+33.7%
0.00%0.0%
Q2 2015$429,00024,3810.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders